what to know before starting a glp 1 Are GLP-1s Safe? GLP-1 Business Opportunities for Pharmacies:

Aliment Pharmacol Ther 56(6):942956 Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, Romero D, Abdelmalek MF, Anstee QM, Arab JP, Arrese M, Bataller R, Beuers U, Boursier J, Bugianesi E, Byrne CD, Castro Narro GE, Chowdhury A, Cortez-Pinto H, Cryer DR, Cusi K, El-Kassas M, Klein S, Eskridge W, Fan J, Gawrieh S, Guy CD, Harrison SA, Kim SU, Koot BG, Korenjak M, Kowdley KV, Lacaille F, Loomba R, Mitchell-Thain R, Morgan TR, Powell EE, Roden M, Romero-Gmez M, Silva M, Singh SP, Sookoian SC, Spearman CW, Tiniakos D, Valenti L, Vos MB, Wong VW-S, Xanthakos S, Yilmaz Y, Younossi Z, Hobbs A, Villota-Rivas M, Newsome PN (2023) A multisociety Delphi consensus statement on new fatty liver disease nomenclature

TIRZEPATIDE Tirzepatide is an advanced weekly GLP-1 and GIP medication that helps support long-term weight management

A systematic review ScienceDirect science/article/pii/S2214623724000048 [58] GLP-1 receptor agonists: A novel pharmacotherapy for binge eating (Binge eating disorder and bulimia nervosa)

Other considerations include individuals with gastrointestinal issues, as semaglutide may cause nausea, vomiting, or diarrhea, especially during the initial stages of treatment

Medication adherence is important for managing chronic conditions, and this is no different

Why did we start with an injection shot